Third, persistently high coagulation potential by thrombin generation was lower after additional adjustment for serial C-reactive protein, anti-Xa level, fibrinogen, SOFA score, incident pulmonary embolism and deep venous thrombosis. The gene discussed is TNXA; the disease is pulmonary embolism.